New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
April 14, 2014
10:02 EDTDDD, OPTT, PCTY, QTWO, SRE, SSYS, ULTI, V, XOOM, MA, LNKD, ACRX, AGII, AI, APAM, BCRX, CPRX, ECOM, KIN, ZBRAOn The Fly: Analyst Initiation Summary
3D Systems (DDD) initiated with a Neutral at Goldman... AcelRx (ACRX) initiated with a Buy at Roth Capital... Argo Group (AGII) initiated with a Market Perform at Keefe Bruyette... Arlington Asset Investment (AI) initiated with a Neutral at Credit Suisse... Artisan Partners (APAM) initiated with an Outperform at RBC Capital... BioCryst (BCRX) initiated with an Outperform at Brinson Patrick... Catalyst Pharmaceutical (CPRX) initiated with an Overweight at Piper Jaffray... ChannelAdvisor (ECOM) initiated with a Buy at Janney Capital... Kindred Biosciences (KIN) initiated with an Outperform at Leerink... LinkedIn (LNKD) initiated with an Overweight at Atlantic Equities... MasterCard (MA) initiated with a Sector Perform at Pacific Crest... Ocean Power (OPTT) initiated with a Buy at H.C. Wainwright... Pandora (P) initiated with a Buy at SunTrust... Paylocity (PCTY) initiated with a Buy at Deutsche Bank... Q2 Holdings (QTWO) initiated with a Buy at Canaccord... Sempra Energy (SRE) initiated with a Buy at UBS... Stratasys (SSYS) initiated with a Buy at Goldman... Ultimate Software (ULTI) initiated with a Buy at Deutsche Bank... Visa (V) initiated with an Outperform at Pacific Crest... Xoom (XOOM) initiated with a Buy at Buckingham... Zebra Technologies (ZBRA) initiated with a Buy at Sidoti.
News For DDD;ACRX;AGII;AI;APAM;BCRX;CPRX;ECOM;KIN;LNKD;MA;OPTT;PCTY;QTWO;SRE;SSYS;ULTI;V;XOOM;ZBRA From The Last 14 Days
Check below for free stories on DDD;ACRX;AGII;AI;APAM;BCRX;CPRX;ECOM;KIN;LNKD;MA;OPTT;PCTY;QTWO;SRE;SSYS;ULTI;V;XOOM;ZBRA the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
August 28, 2014
06:22 EDTDDD3D Systems implied volatility of 41 at lower end of index mean range
06:02 EDTVVisa downgraded to Market Perform from Outperform at Raymond James
Subscribe for More Information
August 26, 2014
11:48 EDTLNKDLinkedIn management to meet with Piper Jaffray
Subscribe for More Information
09:51 EDTLNKDOn The Fly: Analyst Initiation Summary
Cray (CRAY) initiated with a Buy at Stifel... Enphase Energy (ENPH) initiated with a Buy at Needham... FCB Financial (FCB) initiated with a Buy at UBS... FCB Financial initiated with an Overweight at JPMorgan... Goldman Sachs (GS) initiated with a Buy at MKM Partners... HealthEquity (HQY) initiated with a Neutral at RW Bair... Mobileye (MBLY) initiated with a Buy at Deutsche Bank... Mobileye initiated with a Neutral at Goldman... Mobileye initiated with a Neutral at RW Baird... Mobileye initiated with an Overweight at Barclays... RAIT Financial (RAS) initiated with an Outperform at JMP Securities... SunEdison (SUNE) initiated with an Outperform at FBR Capital... Mobileye initiated with an Outperform at Raymond James... Transocean Partners (RIG) initiated with an Overweight at Morgan Stanley... GT Advanced (GTAT) coverage resumed with an Overweight at Piper Jaffray... LinkedIn (LNKD) initiated with an Overweight at First Analysis... CSC (CSC) initiated with a Sector Perform at RBC Capital... United Natural Foods (UNFI) initiated with an Overweight at Stephens.
08:30 EDTVConcerns about payment disintermediation overdone, says Pacific Crest
Subscribe for More Information
07:03 EDTLNKDLinkedIn initiated with an Overweight at First Analysis
Target $280.
August 25, 2014
13:47 EDTMAWal-Mart launching chip-enabled store-brand MasterCard
Subscribe for More Information
07:50 EDTMA, VVisa headwinds likely to subside, says Pacific Crest
Subscribe for More Information
August 21, 2014
16:46 EDTLNKDLinkedIn product head to leave company, effective October 3
Subscribe for More Information
09:07 EDTKINOn The Fly: Pre-market Movers
Subscribe for More Information
08:20 EDTKINKindred Biosciences price target lowered to $19 from $30 at BMO Capital
BMO Capital cut its price target on Kindred after the company announced that its pivotal study of CereKin for the treatment of osteoarthritis in dogs did not meet its primary endpoint. However, the firm thinks that each of two other trials that the company is undertaking has a 70% chance of succeeding. The firm believes that the company has many more shots on goal, and it keeps an Outperform rating on the shares.
August 20, 2014
18:35 EDTKINOn The Fly: After Hours Movers
Subscribe for More Information
16:03 EDTKINKindred reports pivotal field study of CereKin did not meet primary endpoint
Subscribe for More Information
16:00 EDTKINKindred Biosciences trading halted, pending news
Subscribe for More Information
08:01 EDTLNKDAd spending on LinkedIn reportedly rising, says Pacific Crest
Subscribe for More Information
07:38 EDTECOMChannelAdvisor management to meet with Needham
Meetings to be held in San Francisco on August 27 and in San Diego on August 28 hosted by Needham.
07:23 EDTSSYSBrean Capital remains a buyer of Stratasys following management meetings
Subscribe for More Information
August 19, 2014
10:32 EDTLNKDRumor: LinkedIn moves lower on speculation of a large investor short position
07:12 EDTECOM, ULTIStephens to hold a plane trip
Subscribe for More Information
07:06 EDTACRXGuggenheim to hold a conference
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use